<SEC-DOCUMENT>0000905718-22-000202-index.html : 20220210
<SEC-HEADER>0000905718-22-000202.hdr.sgml : 20220210
<ACCEPTANCE-DATETIME>20220210160258
ACCESSION NUMBER:		0000905718-22-000202
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20220210
DATE AS OF CHANGE:		20220210
GROUP MEMBERS:		SHAVIT CAPITAL FUND III (US), L.P.

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chemomab Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001534248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				813676773
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-86953
		FILM NUMBER:		22613842

	BUSINESS ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002
		BUSINESS PHONE:		972-77-331-0156

	MAIL ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anchiano Therapeutics Ltd.
		DATE OF NAME CHANGE:	20180906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioCancell Ltd.
		DATE OF NAME CHANGE:	20111104

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gabriel Capital Management Ltd.
		CENTRAL INDEX KEY:			0001765871
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		JERUSALEM TECHNOLOGY PARK
		STREET 2:		BUILDING 1B, BOX 70
		CITY:			MALHA, JERUSALEM
		STATE:			L3
		ZIP:			9651
		BUSINESS PHONE:		97226490400

	MAIL ADDRESS:	
		STREET 1:		JERUSALEM TECHNOLOGY PARK
		STREET 2:		BUILDING 1B, BOX 70
		CITY:			MALHA, JERUSALEM
		STATE:			L3
		ZIP:			9651
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>chemomab_sc13gadec312021.htm
<DESCRIPTION>SC 13G/A
<TEXT>
Document 1 - file: chemomab_sc13gadec312021.htm

</DOCUMENT>
</SEC-DOCUMENT>